Infectious Diseases research
The Department of Infectious Diseases, Alfred Health and Monash University incorporates a large clinical service.
We have active research programs in the fields of HIV, viral hepatitis, infections in the immunosuppressed (e.g. malignancy, intensive care and post-splenectomy patients), influenza, drug resistant organisms, antibiotic use, infection prevention and hospital epidemiology.
Our Clinical Research Unit conducts single and multi-centre investigator and industry-initiated studies.
- Professor Margaret Hellard was awarded an NHMRC Senior Principal Research Fellowship (2016-2020) for her research program ‘Reducing the impact of blood borne viruses and sexually transmitted infections in young people’.
- Dr James McMahon and Dr Janine Trevillyan were awarded NHMRC Early Career Fellowships to commence in 2016 for their respective projects on prevention of HIV with antiretroviral therapy and eliminating excess cardiovascular risk in people living with HIV.
- Dr Julian Elliott was awarded an NHMRC Partnership Project Grant (2016-2018) of $928,417 to study new approaches to evidence synthesis: ‘Evidence Innovation: transforming the efficiency of systematic review’.
- Professor Allen Cheng is part of the team (CIC), led by University of Sydney’s Professor Tania Sorrell (CIA), awarded a $2.5 million NHMRC Centre of Research Excellence (CRE) in Population Health Research (2016-2021). The CRE is entitled ‘Protecting the public from emerging infectious diseases’.
- Professor Jennifer Hoy (CIB), Professor Suzanne Crowe (CIC) and Dr Julian Elliot (CID) were awarded an NHMRC Project Grant (2016-2018) of $632,037 led by Burnet Institute’s Associate Professor Anthony Jaworowski (CIA) and with Doctor Anna Hearps (CIE) of Burnet Institute (CIE) entitled ‘A new monocyte atherogenic phenotype in chronic HIV disease’
27 PhD students
37 journal articles
PrEPX is a research study that is examining how expanding the use of PrEP impacts the rates of new HIV infections in Victoria. PrEPX will close enrolments in Victoria on March 31.Find out more
PrEPX South Australia
Alfred Health’s highly successful PrEPX study for those at risk for HIV infection has expanded into South Australia thanks to a new partnership with South Australian Health & Medical Research Institute (SAHMRI) and SA Health.Find out more
Alfred Health’s highly successful PrEPX study for those at risk for HIV infection will be expanded into Tasmania thanks to funding from the Tasmanian Government.Find out more
Alfred Health is a leader in HIV research, with a national and international profile encompassing basic science, clinical research and translational research.Find out more
General infectious diseases
The General Infectious Disease team and the Cardiothoracic Unit reviewed the occurrence of bacteremia in patients receiving ventricular assist device implants between 1990 and 2009.Find out more
The unit contributes significant laboratory and clinical data to the Australian Group on Antibiotic Resistance resulting in regular publications that supply critical data on trends and resistance in Australia.Find out more
Infections in the immunosuppressed host
The Immunocompromised Host Service studies prevention, diagnosis and treatment of invasive fungal disease.Find out more
Viral hepatitis study
The Hepatitis C virus (HCV) Treatment and Prevention (TAP) study is a world first study examining the feasibility of treating with direct acting antiviral drugs using a nurse led model of care in a community based environment for a cohort of HCV-positive people who inject drugs.Find out more
Colliding epidemics and the rise of cryptococcosis
Chang CC, Chen SC-A
(2016), J Fungi, 2(1),
Tenofovir therapy for hepatitis B may be commonly prescribed without HIV testing
Deshpande S, Ko T, Roberts E, Lau JS, Horne K, Williams J, Kiss C, Ratnam D, Woolley I
(2016), J Acquir Immune Defic Syndr, 71(2),
Do people with HIV infection have a higher risk of fracture compared with those without HIV infection?
Hoy J, Young B
(2016), Curr Opin HIV AIDS, 11(3),